Sector ratings Bolt Biotherapeutics, Inc.
Equities
BOLT
US0977022039
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.780 USD | -4.40% |
|
+2.36% | -12.58% |
| 05-12 | Bolt Biotherapeutics reports first quarter 2026 financial results | RE |
| 05-12 | Bolt Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 9.19M | - | - | - | - | ||||
| 50.1B | A | |||||||
| 45.82B | AAA | |||||||
| 23.66B | - | A | - | - | ||||
| 22.65B | - | - | - | - | ||||
| 17.8B | AAA | |||||||
| 16.08B | A | |||||||
| 14.14B | B | |||||||
| 13.09B | - | - | - | - | ||||
| 13B | - | AA | - | - | ||||
| 12.6B | BB | |||||||
| 12.07B | - | B | - | - | ||||
| 10.8B | - | BB | - | - | ||||
| 9.73B | AA | |||||||
| 8.42B | AA | - | ||||||
| 8.35B | - | CCC | - | - | ||||
| 8.32B | - | |||||||
| 8.08B | - | CCC | - | - | ||||
| 7.56B | - | BBB | - | - | ||||
| 7.26B | B | |||||||
| Average | 15.48B | A | |||||||
| Weighted average by Cap. | A |
- Stock Market
- Equities
- BOLT Stock
- Sector Bolt Biotherapeutics, Inc.
- Sector ratings
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition